Sarepta Therapeutics, Inc. (SRPT)
17.50
-0.07
(-0.40%)
USD |
NASDAQ |
Oct 02, 16:00
17.50
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Net Income (Quarterly) : -4.89M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.89M |
| March 31, 2026 | 330.96M |
| December 31, 2025 | -412.23M |
| September 30, 2025 | -179.95M |
| June 30, 2025 | 196.89M |
| March 31, 2025 | -447.51M |
| December 31, 2024 | 159.05M |
| September 30, 2024 | 33.61M |
| June 30, 2024 | 6.46M |
| March 31, 2024 | 36.12M |
| December 31, 2023 | 45.66M |
| September 30, 2023 | -40.94M |
| June 30, 2023 | -23.94M |
| March 31, 2023 | -516.76M |
| December 31, 2022 | -109.24M |
| September 30, 2022 | -257.74M |
| June 30, 2022 | -231.48M |
| March 31, 2022 | -105.02M |
| December 31, 2021 | -121.98M |
| September 30, 2021 | -48.14M |
| June 30, 2021 | -81.40M |
| March 31, 2021 | -167.25M |
| December 31, 2020 | -189.32M |
| September 30, 2020 | -196.50M |
| June 30, 2020 | -150.82M |
| Date | Value |
|---|---|
| March 31, 2020 | -17.49M |
| December 31, 2019 | -235.70M |
| September 30, 2019 | -126.33M |
| June 30, 2019 | -276.40M |
| March 31, 2019 | -76.64M |
| December 31, 2018 | -140.90M |
| September 30, 2018 | -76.39M |
| June 30, 2018 | -109.27M |
| March 31, 2018 | -35.36M |
| December 31, 2017 | -24.00M |
| September 30, 2017 | -47.73M |
| June 30, 2017 | -63.05M |
| March 31, 2017 | 84.09M |
| December 31, 2016 | -88.45M |
| September 30, 2016 | -56.74M |
| June 30, 2016 | -62.30M |
| March 31, 2016 | -59.77M |
| December 31, 2015 | -64.68M |
| September 30, 2015 | -51.94M |
| June 30, 2015 | -41.85M |
| March 31, 2015 | -61.56M |
| December 31, 2014 | -44.42M |
| September 30, 2014 | -29.23M |
| June 30, 2014 | -33.87M |
| March 31, 2014 | -28.27M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Moderna, Inc. | -782.00M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Beam Therapeutics, Inc. | -122.68M |
| ImmunityBio, Inc. | -230.39M |
| Twist Bioscience Corp. | -35.05M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 401.25M |
| Total Expenses (Quarterly) | 406.14M |
| EPS Diluted (Quarterly) | -0.0464 |
| Enterprise Value | 2.106B |
| Gross Profit Margin (Quarterly) | 60.18% |
| Profit Margin (Quarterly) | -1.22% |
| Earnings Yield | -16.56% |
| Normalized Earnings Yield | -9.785 |